Following the online publication of this article, the authors noted the following errors:
1. The third sentence of the abstract should read 'An improvement of more than or equal to 50% in the ADHD Rating Scale-IV (ARS) scores after 8 weeks of treatment compared with the baseline ARS scores before the treatment was considered as a 'good response', whereas an improvement of less than 50% was considered as a 'poor response' '.
The first sentence under the subhead 'DRD4-Exon3
Genotype Determination' should read 'The DRD4-exon III repeat region was genotyped by a PCR-based length polymorphism'.
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